Archive: Recommended Stocks & Mutual Funds in the News

08/05/2005 --- Gen-Probe Inc. Continues to Exceed Wall Street Expectations

On Monday, medical test maker Gen-Probe Inc. (GPRO) exceeded Wall Street expectations by reporting a 24% increase in product sales and a 14% rise in earnings per share. The company also raised its full-year forecast. For the week, GPRO's stock was up 7.2%. Since being added to our Primary Stock Portfolio, the company's stock has risen 293.2%.

07/29/2005 --- Granite Construction's 2nd Qtr Results Exceed Wall Street's Expectations

Granite Construction's stock price rose (+7.6%) this week, increasing the stock's overall gain to (+111%) since being added to our High Dividend Portfolio. This week's gain was caused by Wall Street analysts once again underestimating the company's quarterly performance. Revenue increased from $558.8 million a year ago to $676.7 million for the 2nd quarter of 2005. Meanwhile, the company's backlog of orders increased +25% compared to the 2nd quarter of 2004.

07/22/2005 --- Profits At Cavco Industries Inc. Doubled

Profits at Cavco Industries Inc. (CVCO) doubled according to the company's latest quarterly results. On Wednesday, the company announced that net income in the first quarter jumped from $0.26 per share a year ago to $0.53 for the first quarter of fiscal year 2005. The profits exceeded Wall Street's estimates by 26%. Cavco's stock jumped 14.5% this week and has risen 206.7% since we issued a buy signal for the company. Two recent buy recommendations that are also out-performing expectations are GameStop Corp. (GME) and Freescale Semiconductor Inc. (FSL). The stocks of these two companies are up 69.4% and 40.3% respectively in the time since we emailed the buy signals to subscribers four months ago.

07/15/2005 --- Semiconductor Company Awarded Major Contract, Stock Up 43% Since March

On Tuesday, Freescale Semiconductor Inc. (FSL) was selected by Motorola to provide high-speed chips for Motorola cell phones. The contract runs through 2008. Motorola is the world's second largest mobile phone manufacturer. In addition to phone chips, Freescale provides powertrain control solutions for 8 of the 12 winners of the "International Engine of the Year" awards. Freescale's stock rose 4.41% on the day of the announcement, gained 11% this week, and has risen 43.2% since being added to this portfolio in March of this year. Investor optimism for the company has pushed the the stock's price up recently in anticipation of the company's quarterly earnings release on July 19.

07/09/2005 --- Select Portfolios Up 5% This Week, 22% In June

Aided by the strong moves of stocks such as Gen-Probe Inc. (+11.1% this week) and Giant Industries Inc. (+8.0%), our Primary Stock Portfolio and Double Allocation* stocks made gains of 5.4% and 5.1% respectively this past week. In fact all of our stock portfolios were able to out-perform the S&P 500 this week. Year-to-date, our Double Allocation stocks are up 47% after commissions. The 47% return assumes gains are not reinvested, and would be higher if an investor reinvested any gains.

Additionally, each month we run our Cornerstone Growth Stock screen. The 3 Cornerstone stocks receiving our highest recommendation for the month of June gained 22% in the 30 days following their recommendation.

*Double Allocation Stocks are the stocks in our Short-Term Portfolio that receive our highest recommendation.

07/01/2005 --- Half Way Through the Year: Portfolio Returns of 44.1%, 24.7%, & 21.5% While S&P 500 Down (-1.4%)

At the midway point of the year, our best performing recommendations are our Double Allocation stocks*. Year-to-date, these stock have returned 44.1%. Since inception in September 2004, the stocks have returned 81.1%. Our second-best performers are from our Industry/Sector Spotlight with a year-to-date return of 24.7%. Coming in third is our Short-Term Portfolio which has a return of 21.5% through June. In comparison, the S&P 500 has lost ground this year (-1.4%).

*Double Allocation Stocks are the stocks in our Short-Term Portfolio that receive our highest recommendation.

06/26/2005 --- WLDA's 13.3% Gain This Week Boosts Stock's Return to 42% in Seven Weeks.

World Air Holdings (WLDA) saw its stock rise 13.25% this week for a total gain of 42% since being purchased seven weeks ago. WLDA is a Double Allocation stock*. These stocks have risen 75.1% since last September and 38.4% year-to-date. The S&P 500 has fallen 1.7% this year.

*Double Allocation Stocks are the stocks in our Short-Term Portfolio that receive our highest recommendation. On average, there are 3-4 stocks receiving this status at any given time.

06/17/2005 --- Short-Term Portfolio Gains 4.1% This Week, Boosting Return to 45.9% in Nine Months

Behind the gains of companies like Imergent Inc. (+16.4% this week), Giant Industries Inc. (+11.3%), and Timken Co. (+7.9%), our Short-Term Portfolio rose 4.1% this week, boosting the portfolio's return to 45.9% in nine months. That's an annualized return of 64.8% and assumes gains are not reinvested. If gains were reinvested, the portfolio's return would be higher. Year-to-date, the portfolio's return is 19.7% versus 0.4% for the S&P 500's.

Stocks in the Short-Term Portfolio that receive our highest rating are called "Double Allocation" stocks and have provided a gain of 72.8% since September 14, 2004. That's equivalent to an annualized gain of 106.2%. Year-to-date, our "Double Allocation" stocks have gained 36.3% versus 0.4% for the S&P 500's.

06/10/2005 --- MLB Sold For a Gain of 56.1%

In July of 2003 we issued a buy signal for Mitchells & Butlers PLC (MLB). Including reinvestment of dividends, the stock has risen 56.1%. The average sell signal for our Primary Stock Portfolio has resulted in a gain of 85.9% with 72.5% of the trades generating a profit.

06/03/2005 --- 9% Gain This Week By SCST Pushes Total Profit To 113.1%

SCS Transportation Inc. (SCST), a Missouri-based trucking company, saw its stock advance 9% this week. This pushes the stock's gain to 113.1% since we issued a buy signal for the company in December of 2002. On May 3, the company announced that its Board of Directors had authorized the repurchase of up to $20 million of its common stock.

05/28/2005 --- 139% Gain On Sale of EPAX; GME Up 46.9% In 11 Weeks

We issued a sell signal for Ambassadors Group Inc. (EPAX) this week, resulting in a gain of 139% versus a 12.1% move in the S&P 500. On Tuesday, shares of GameStop Corp. (GME) rose 6.6% on news that the company's profits jumped 54% during the first quarter, exceeding Wall Street's expectations. GME's stock has risen 46.9% since we issued a buy signal for the company eleven weeks ago.

05/14/2005 --- Leading Portfolio Up 7% This Week

With inflation worries fading a bit this week, our stock picks took off. Leading the way, as usual, were Double Allocation stocks like World Airways Inc. (+13.0% this week), Imergent Inc. (+11.9%), and Reliance Steel & Aluminum Co. (+11.1%). Since we started posting our Double Allocation stocks last September, these volatile stocks have turned in a gain of 69% versus 5.4% for the S&P 500. Year-to-date, their gain is 30% versus a loss
(-1.9%) for the S&P 500.

Stock Portfolio Performances This Week:

*Our highest-rated stocks in the Short-Term Portfolio

05/14/2005 --- Cimarex Energy Co. About to Become Much Larger

Cimarex Energy Company, part of our Primary Stock Portfolio, has seen its stock rise 100.9% since we issued a buy signal for the company. Cimarex is on the verge of expanding its empire. The company is set to merge with Magnum Hunter Resources Inc. (MHR). On Tuesday, Magnum reported record quarterly results, including a 29% jump in net income. A shareholder vote on the merger has been set for Monday, June 6th.

05/06/2005 --- Three New Portfolios

We have added three new portfolios to our site. One is designed to excel in bear markets. It chooses stocks from industries that averaged a 19.1% gain per year during the 2000-2003 bear market. Another was created for subscribers who have requested ideas for getting started in socially responsible investing. And the third is a stock screen that achieved an annualized return of 41.4% over the last three years. We developed the screen by modifying a stock screen that had provided an 18.82% annual return over a 43 year period. Our modifications created more stringent requirements, particularly in the area of cash flow and relative price strength.

04/29/2005 --- 146.6% Gain For This Home-Builder

Yesterday's announcement that net income jumped 159% during the latest quarter sent shares of Cavco Industries Inc. (CVCO) up 9.3% today. The producer of manufactured homes has seen its stock rise 146.3% after we issued our buy signal for the home-builder. Net income for the year increased 83% to $10,127,000 versus $5,522,000 for last year.

04/22/2005 --- To Beat The Market, A Company Has to Beat Wall Street's Estimates

To beat the market, you must do more than just buy profitable companies. You have to buy companies that will perform better than Wall Street's expectations. That's because stock prices have future expectations already built into the stock's price. And while out-smarting Wall Street's stock analysts may sound like a daunting task, it's possible for the individual investor to do just that as our long-term performance record demonstrates. This week several of our recommended stocks reported quarterly earnings that exceeded analyst's forecasts. Among them were Timken Co. (ticker: TKR), MoneyGram International Inc. (MGI), Altria Group Inc. (MO), Reliance Steel And Aluminum Co. (RS), SCS Transportation Inc. (SCST), and OMI Corporation (OMM).

04/15/2005 --- Our Top 5 Gainers Since Date of Recommendation:

*Including dividends

04/08/2005 --- Arbitration Victory Boosts GPRO 6% This Week, 316% Overall
Gen-Probe Inc. (GPRO) tentatively prevailed in court and saw its stock price rise nearly 6% this week. The stock has risen 315.8% since we issued a buy signal for the medical company. Gen-Probe received a tentative award in its arbitration with Bayer HealthCare, LLC concerning the parties' collaboration for the development and sale of nucleic acid diagnostic tests for viral organisms. The arbitrator determined that Gen-Probe is entitled to a co-exclusive right to distribute qualitative TMA assays to detect the hepatitis C virus and HIV-1. Bayer previously held the exclusive rights to market these products. The tentative decision is subject to further proceedings related to implementation of the decision. Gen-Probe expects the decision to remain substantially unchanged.

04/01/2005 --- 1st Quarter 2005: Beating the Market Again
Three months into the new year and the results are excellent. Our Primary Stock Portfolio and all of our alternative portfolios are out-performing the stock market this year. Leading the way is a 45.4% year-to-date gain by the Double Allocation stocks (the highest-recommended stocks that comprise our Short-Term Portfolio). In comparison, the S&P has fallen (-3.3%) in the first quarter of the year. Also performing exceptionally well is our Industry/Sector Analysis Portfolio, which is up 16.5% in the first quarter.

A specific example of our success is Gen-Probe Inc. (GPRO), which is part of our Primary Stock Portfolio. The company's stock is up +265.1% since we released a buy signal for in January of 2003.

03/19/2005 --- Kaydon Corp. Up 6.3% On Tuesday's Upgrade
Kaydon Corporation, a custom-engineered products manufacturer, was upgraded from "neutral" to "outperform" by research firm Robert W. Baird on Tuesday, boosting the company's stock 6.3%. Also making significant gains this week was the stock of AngioDynamics. The stock of the medical device manufacturer rose 16% this week. Kaydon Corp. and AngioDynamics are stocks we are currently recommending.

03/11/2005 --- Today's Sale of FDG & IGI Results in Gains of 539% & 129% Respectively
Fording Canadian Coal Trust (FDG) was sold today for a gain of 539.2% while Imagistics International (IGI) was sold for a gain of 129.4%. Past stock sales from our Primary Stock Portfolio have resulted in an average gain of 89.2%. Two stocks were added to the Primary Stock Portfolio to replace FDG and IGI.

03/04/2005 --- Barron's Says Cavco Still Cheap--Our Results: 154.5% Gain
Barron's financial weekly said that they believe Cavco Industries Inc. (CVCO) is still "cheap" despite the fact that the company's stock has more than doubled in the last 17 months. The debt-free home-building company has seen its stock rise 154.5% since we issued a buy signal for the company seventeen months ago. Barron's positive statements helped boost Cavco's stock 11.07% this week.

02/25/2005 --- +33.2% Year-To-Date: Successfully Targeting Hot Industries
Several of the stocks in our Short-Term Portfolio show so much potential that we recommend allocating twice the normal investment into each. Year-to-date, these stocks have returned 33.2%. Since we started tracking them on 9/14/2004, they have returned 71.2%. Such high returns have come from successfully targeting hot stocks in hot industries. Currently, steel-making companies have been the target. Companies such as Posco (PKX) and United States Steel Corp. (X) have greatly contributed to this portfolio's high returns in 2005. In 2004, this portfolio successfully targeted oil companies.

02/18/2005 --- 6.3% Gain This Week Pushes GPRO's Total Gain to 320.7%
The stock of Gen-Probe Inc. (GPRO) gained 6.3% this week as they reported earnings that were 21% higher than Wall Street had expected. Revenue and earnings for 2004 set records for the San Diego based company. Gen-Probe expects another year of strong product sales growth in 2005. Overall, Gen-Probe's stock is up 320.7% since we issued a buy signal for the company.

02/11/2005 --- Two More Recommended Stocks Report Significant Increases In Earnings
The stock of FMC Technologies Inc. was up 6.9% this week on news that the company exceeded analyst earnings estimates by 62.5%. Overall, FMC is up 62.1% for our Primary Stock Portfolio. Imagistics International Inc. (IGI) also reported an increase in quarterly profits this week. Earnings per share rose 40%, the company raised their 2005 earnings estimate, and the stock is now up 125.7% since we sent out our buy signal for the company.

02/04/2005 --- 62.5% Gain in Less Than Six Months
Our Short-Term Stock Portfolio is producing a gain of 50.7% after commissions (equivalent to 134.3% per year) since 8/20/2004. Furthermore, a subset of the portfolio that we designate as "double allocation" has returned 62.5% since 8/20/2004. Over the same time period, the S&P 500's return was only 9.5%.

01/21/2005 --- Wall Street is Finally Noticing Our Oil/Gas Stock
This week Barron's published a feature article on Cimarex Energy Co. (XEC), stating that the company is "awfully cheap, " has a "pristine" balance sheet, and employs a "super-conservative" method of booking reserves. The stock jumped 6.5% this week, despite the S&P 500 falling 1.4%. We recommended Cimarex Energy to our subscribers when the stock was selling for $17.21, resulting in a gain of 128.5% so far.

01/14/2005 --- 38.5% Gain for Short-Term Portfolio Since 8/20/2004
While the S&P 500 is showing a loss thus far in 2005, our Short-Term Portfolio is showing a gain. The portfolio, which has an inception date of August 20, 2004, is up 38.5% in five months. Over the same time period, the S&P 500 is up only 7.8%. For more information about our Short-Term Portfolio, go here.

01/08/2005 --- Gen-Probe Receives FDA Marketing Clearance for Standalone APTIMA Test Up 265.5% since we put the company on our buy list, Gen-Probe (ticker GPRO) announced that the U.S. Food and Drug Administration (FDA) has granted marketing clearance for the Company's APTIMA® CT assay, an amplified nucleic acid test. Gen-Probe has more than 20 years of nucleic acid detection research and product development experience, and its products are used daily in clinical laboratories and blood collection centers throughout the world. Gen-Probe is headquartered in San Diego, California and employs approximately 900 people.

01/02/2005 --- 2004 Performance

For the seventh year in a row, our flagship portfolio, the Primary Stock Portfolio, outperformed the S&P 500. It finished up 28.1% for the year versus 8.9% for the S&P 500.

Our 2004 Portfolio Performance:

*Return percentages may increase as dividends are factored in for late-reporting companies.

Top Individual Sales In 2004:

More Archived Articles

Above are updates on some of our recommended stocks and mutual funds. If you want to see exactly what stocks and funds we recommend and when to buy and sell them, subscribe today. You'll receive a complete listing of all of our recommended stocks, mutual funds, and brokerage firms.

Portfolio Overviews

| Home | Performance | Current Recommendations |
| Articles | How it Works | FAQ's | Investing 101 |
| About Us | Contact Us | Subscribe

Copyright © 1992 - BeatTheStockMarket.com LLC
Do not duplicate or redistribute in any form
Disclaimer and Terms of Service Agreement
All rights reserved
Privacy Policy